ScholarLens Back to search
2023•Unpublished venueOpen access

Supplementary Data from BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression

Lijie Xing, Su Wang, Jiye Liu, Tengteng Yu, Hailin Chen, Kenneth Wen, Yuyin Li, Liang Lin, Phillip A. Hsieh, Shih‐Feng Cho, Gang An, Lugui Qiu, Krista Kinneer, Nikhil C. Munshi, Kenneth Carl Anderson, Yu‐Tzu Tai

Open full text 0 citations

Abstract

Supplementary materials

About this research paper

What this paper is about

Supplementary materials

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Supplementary materials

Key concepts: Daratumumab, CD38, Cytotoxicity, Cancer research, Multiple myeloma, Immune system, Chemistry, Computational biology

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Supplementary Data from BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression — Research Paper | ScholarLens